本页面由Tiger Trade Technology Pte. Ltd.提供服务

Caris Life Sciences, Inc.

29.69
-0.0100-0.03%
盘后:29.690.00000.00%19:30 EDT
成交量:499.76万
成交额:1.47亿
市值:83.77亿
市盈率:79.81
高:30.13
开:29.94
低:28.49
收:29.70
52周最高:33.65
52周最低:14.19
股本:2.82亿
流通股本:1.16亿
量比:1.06
换手率:4.31%
股息:- -
股息率:- -
每股收益(TTM):0.3720
每股收益(LYR):-3.2200
净资产收益率:20.13%
总资产收益率:8.77%
市净率:14.16
市盈率(LYR):-9.22

数据加载中...

2026/09/22

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/09/17

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/09/15

重要事件披露

Form 8-K - Current report
2026/09/04

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/09/04

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/08/24

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/08/12

超过5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/08/07

超过5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/08/07

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/08/05

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/08/05

重要事件披露

Form 8-K - Current report
2026/08/03

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/06/05

重要事件披露

Form 8-K - Current report
2026/05/13

超过5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/05/12

超过5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/05/08

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/05/08

重要事件披露

Form 8-K - Current report
2026/04/07

超过5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/04/02

重要事件披露

Form 8-K - Current report
2026/03/04

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]